Literature DB >> 630688

Coronary sinus reflux. A source of error in the measurement of thermodilution coronary sinus flow.

D G Mathey, K Chatterjee, J V Tyberg, J Lekven, B Brundage, W W Parmley.   

Abstract

In seven patients thermodilution coronary sinus flow (TD-CSF) was higher (164 +/- 21 ml/min) during ventricular pacing than during atrial pacing (119 +/- 21 ml/min, P less than 0.005) at identical heart rate, without an increase in the determinants of myocardial oxygen consumption. To assess the possibility of right atrial admixture in coronary sinus blood during ventricular pacing we compared electromagnetic coronary arterial blood flow (CBF) with TD-CSF in nine dogs during interventions that increased right atrial pressure. During ventricular pacing, rapid atrial pacing, pulmonary artery constriction and increased intrathoracic pressure, right atrial pressure increased and electromagnetic CBF was significantly less (41-166%) than TD-CSF. Marked reflux from the right atrium to the coronary sinus was also demonstrated by bolus injection of cold saline into the right atrium and continuous infusion of contrast material into coronary sinus. Caution needs to be exercised in interpreting TD-CSF in the presence of changing right atrial pressure.

Entities:  

Mesh:

Year:  1978        PMID: 630688     DOI: 10.1161/01.cir.57.4.778

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  The comparative cardiovascular effects of sevoflurane with halothane and isoflurane.

Authors:  T Kazama; K Ikeda
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

2.  Myocardial oxygen supply:demand ratio as reference for coronary vasodilatory drug effects in humans.

Authors:  I Vergroesen; J E Kal; J A Spaan; H B Van Wezel
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

3.  Coronary sinus dilatation is associated with left ventricular systolic dysfunction and poor functional status in subjects with chronic heart failure.

Authors:  Murat Yuce; Vedat Davutoglu; Sema Yavuz; Ibrahim Sari; Nese Kizilkan; Suleyman Ercan; Murat Akcay; Cayan Akkoyun; Adnan Dogan; Hayri Alici; Murat Cavdar; Hasan Buyukarslan
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

Review 4.  Glossary: methods for the measurement of coronary blood flow and myocardial perfusion.

Authors:  S G Sakka; D R Wallbridge; G Heusch
Journal:  Basic Res Cardiol       Date:  1996 Mar-Apr       Impact factor: 17.165

5.  Clinical methods to determine coronary flow and myocardial perfusion.

Authors:  M J Wolters-Geldof; V M Cats; A V Bruschke
Journal:  Int J Card Imaging       Date:  1997-04

6.  Metabolic fate of extracted glucose in normal human myocardium.

Authors:  J A Wisneski; E W Gertz; R A Neese; L D Gruenke; D L Morris; J C Craig
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

7.  Alterations in angina threshold with nifedipine during pacing induced angina.

Authors:  P H Kramer; K Chatterjee; A Schwartz; K Swedberg; J L Rouleau; D Curran; L Blevins; W W Parmley
Journal:  Br Heart J       Date:  1984-09

8.  Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.

Authors:  P Daly; J L Rouleau; D Cousineau; J H Burgess; K Chatterjee
Journal:  Br Heart J       Date:  1986-08

9.  Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy.

Authors:  D S Thompson; N Naqvi; S M Juul; R H Swanton; D J Coltart; B S Jenkins; M M Webb-Peploe
Journal:  Br Heart J       Date:  1980-11

Review 10.  Coronary microvascular resistance: methods for its quantification in humans.

Authors:  Paul Knaapen; Paolo G Camici; Koen M Marques; Robin Nijveldt; Jeroen J Bax; Nico Westerhof; Marco J W Götte; Michael Jerosch-Herold; Heinrich R Schelbert; Adriaan A Lammertsma; Albert C van Rossum
Journal:  Basic Res Cardiol       Date:  2009-05-26       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.